FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly a pharmaceutical composition for treating venous insufficiency. The pharmaceutical composition in the form of an oral suspension for treating venous insufficiency, which contains as an active component a fine and pure flavonoid fraction containing diosmin, hesperidin, isoroifolin, linarin and diosmin in a certain amount, and as an excipient - xanthan gum.
EFFECT: above composition is uniform and stable; it is effective for treating venous insufficiency.
6 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION IN FORM OF CHEWABLE TABLET OF DIOSMIN OR FLAVONOID FRACTION | 2019 |
|
RU2811866C2 |
| COMPOSITION FOR PHLEBOPROTECTOR AND A METHOD OF ITS PREPARATION | 2021 |
|
RU2806345C2 |
| ORAL SUSPENSION CONTAINING HIGH DOSE OF MOFETIL MYCOPHENOLATE | 1994 |
|
RU2150942C1 |
| LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | 2019 |
|
RU2783413C2 |
| LIQUID ORAL PHARMACEUTICAL DOSAGE FORM CONTAINING HISTAMINE H2-RECEPTOR ANTAGONIST AND ANTACID | 2017 |
|
RU2761346C2 |
| LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | 2019 |
|
RU2810115C2 |
| FEXOFENADINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEREOF | 2010 |
|
RU2563623C2 |
| PHARMACEUTICAL COMPOSITION, MADE OF VICIA ABBREVIATA HERB USED AS ENDOTELYOPROTECTIVE AGENT | 2015 |
|
RU2653468C2 |
| SOLID MEDICINAL FORM, CONTAINING PROTON PUMP INHIBITOR, AND SUSPENSION OBTAINED FROM IT | 2005 |
|
RU2397756C2 |
| PHARMACEUTICAL COMPOSITION OF SILDENAFIL CITRATE IN FORM OF SUSPENSION FOR ORAL ADMINISTRATION | 2016 |
|
RU2649834C1 |
